Renba Liang

4PUBLICATIONS
2CO-AUTHORS
Medical infection agents (incl. prions)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 26, 2022
Depicting the Implication of miR-378a in Cancers.

Yuelan Qin, Renba Liang, Pingan Lu

|Jul 18, 2022
Clinical Significance of Pim-1 in Human Cancers: A Meta-analysis of Association with Prognosis and Clinicopathological Characteristics.

Lin Lai, Xinyu Chen, Ge Tian

|Jan 28, 2021
Nimotuzumab, an Anti-EGFR Monoclonal Antibody, in the Treatment of Nasopharyngeal Carcinoma.

Renba Liang, Liu Yang, Xiaodong Zhu

|Aug 18, 2020
Letter to the editor Re: Pan et al. "LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer".

Renba Liang

Pageof 1

Frequent Collaborators

1 joint publications

Lin Lai

1 joint publications

Xiaodong Zhu